MFIC

Business Context and Reporting Period

This summary covers the Form 10-Q filed by Apollo Investment Corporation (AINV) for the quarterly period ended September 30, 2019. The company is a closed-end, externally managed business development company (BDC) and regulated investment company (RIC) focused on generating current income and capital appreciation through debt and equity investments in private middle-market companies.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total investment income increased by $7.2 million (5.6%) compared to the prior year period, driven primarily by a larger income-bearing portfolio. However, the average yield on the total debt portfolio decreased to 9.8% from 10.7%.
• Expense Increases: Net expenses rose to $66.6 million from $65.9 million. This was primarily due to a $7.9 million increase in interest and other debt expenses, reflecting higher average debt outstanding ($1.37 billion vs. $0.99 billion) and increased leverage (1.24x vs. 0.68x). These increases were partially offset by a $6.6 million decrease in management and incentive fees due to a new total return-based fee structure effective January 1, 2019.
• Capital Losses: The company recognized net realized losses of $10.2 million, compared to $31.3 million in the prior year. Significant losses included a $6.4 million realized loss on Crowne Automotive. Net unrealized losses were $29.2 million, driven by declines in Spotted Hawk ($19.3 million) and KLO Holdings ($8.5 million).
• Debt Redemption: On August 12, 2019, the company redeemed its entire $150 million aggregate principal amount of 2043 Notes, resulting in a realized loss on extinguishment of debt of $4.4 million.

Guidance, Outlook, and Risks

• Portfolio Composition: As of September 30, 2019, 94.4% of investments were classified as Level 3 (unobservable inputs). The portfolio is heavily weighted toward secured debt (91%), with significant exposure to Healthcare & Pharmaceuticals (19.9%) and Business Services (13.3%).
• Liquidity: The company maintains a Senior Secured Facility with $1.71 billion in commitments. As of the reporting date, $464.4 million of unused capacity remained available. Cash equivalents totaled $31.6 million.
• Share Repurchases: The company continues its share repurchase program. During the six months ended September 30, 2019, it repurchased 1.83 million shares for $29.3 million at an average price of $16.03. Approximately $49.7 million remains available under the current plans.
• Risks: The company faces risks related to the creditworthiness of portfolio companies, interest rate fluctuations (100% of the debt portfolio is floating rate), and the valuation of Level 3 assets. A significant legal proceeding remains pending regarding a fraudulent conveyance claim involving DSI Renal Holdings, though the company intends to vigorously defend itself.

Investor Verification Checklist

• Debt Covenants: Verify continued compliance with the 150% asset coverage ratio and borrowing base requirements under the Senior Secured Facility.
• Level 3 Valuations: Review the significant unobservable inputs (discount rates, EBITDA multiples) used to value the 94.4% of the portfolio classified as Level 3, particularly for distressed assets like Spotted Hawk and KLO Holdings.
• PIK Income: Monitor the ratio of Payment-in-Kind (PIK) income to total investment income, as this non-cash income must be distributed to maintain RIC status but does not provide immediate liquidity.
• Legal Proceedings: Track the status of the DSI Renal Holdings litigation, which seeks approximately $41 million in damages from the company.
• Share Repurchase Activity: Confirm the pace of share repurchases and the remaining authorization under the $250 million plan to assess potential accretion to NAV.